Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4039)
All Articles published online
|
Apr 14, 2005 (publication date) through Dec 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ou DP, Yang LY, Huang GW, Tao YM, Ding X, Chang ZG. Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV. World J Gastroenterol 2005; 11(14): 2061-2066 [PMID: 15810069 DOI: 10.3748/wjg.v11.i14.2061] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i14/2061.htm |
| Number | Citing Articles |
| 1 |
Fan Wu, Si‐Yu Liu, Yi‐Ming Tao, Di‐Peng Ou, Feng Fang, Lian‐Yue Yang. Decreased expression of methyl methansulfonate and ultraviolet‐sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma. Cancer 2008; 112(9): 2002 doi: 10.1002/cncr.23396
|
| 2 |
Zixiong Li, Ning Han, Xueying Ren, Yuanjing Zhang, Xiaoyuan Chu. Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.833884
|
| 3 |
Mayuko Furuta, Masaki Ueno, Akihiro Fujimoto, Shinya Hayami, Satoru Yasukawa, Fumiyoshi Kojima, Koji Arihiro, Yoshiiku Kawakami, Christopher P. Wardell, Yuichi Shiraishi, Hiroko Tanaka, Kaoru Nakano, Kazuhiro Maejima, Aya Sasaki-Oku, Naoki Tokunaga, Keith A. Boroevich, Tetsuo Abe, Hiroshi Aikata, Hideki Ohdan, Kunihito Gotoh, Michiaki Kubo, Tatsuhiko Tsunoda, Satoru Miyano, Kazuaki Chayama, Hiroki Yamaue, Hidewaki Nakagawa. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors. Journal of Hepatology 2017; 66(2): 363 doi: 10.1016/j.jhep.2016.09.021
|
| 4 |
Di‐Peng Ou, Yi‐Ming Tao, Fa‐Qing Tang, Lian‐Yue Yang. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. International Journal of Cancer 2007; 120(6): 1208 doi: 10.1002/ijc.22452
|
| 5 |
Xuedong Li, Qing Chen, Dan Yin, Shiming Shi, Lei Yu, Shaolai Zhou, Erbao Chen, Zhengjun Zhou, Yinghong Shi, Jia Fan, Jian Zhou, Zhi Dai. Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma. Oncology Reports 2017; 37(6): 3313 doi: 10.3892/or.2017.5616
|
| 6 |
Jing‐Feng Qiu, Jia‐Zhou Ye, Xu‐Zhuo Feng, Ya‐Peng Qi, Liang Ma, Wei‐Ping Yuan, Jian‐Hong Zhong, Zhi‐Ming zhang, Bang‐De Xiang, Le‐Qun Li. Pre‐ and post‐operative HBsAg levels may predict recurrence and survival after curative resection in patients with HBV‐associated hepatocellular carcinoma. Journal of Surgical Oncology 2017; 116(2): 140 doi: 10.1002/jso.24628
|
| 7 |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang, Jia-Jie Zhang. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World Journal of Gastroenterology 2021; 27(17): 2025-2038 doi: 10.3748/wjg.v27.i17.2025
|
| 8 |
Xiuzhu Huang, Zebin Xiao, Yuyang Zhang, Na Lin, Meilian Xiong, Xinyao Huang, Qi Chen, Dairong Cao. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine–Enhanced Magnetic Resonance Imaging and Pathologic Grade. Journal of Computer Assisted Tomography 2018; 42(3): 365 doi: 10.1097/RCT.0000000000000707
|
| 9 |
Myung Hee Yoon, Young Il Choi, Kwang Kuk Park, Dong Hoon Shin, Chung Han Lee. Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2011; 15(2): 83 doi: 10.14701/kjhbps.2011.15.2.83
|
| 10 |
M. Kiyici, M. Yilmaz, M. Akyildiz, C. Arikan, U. Aydin, D. Sigirli, D. Nart, F. Yilmaz, T. Ozacar, Z. Karasu, M. Kilic. Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation. Transplantation Proceedings 2008; 40(5): 1511 doi: 10.1016/j.transproceed.2008.03.156
|
| 11 |
Wang Gu, Zhong Tong. Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis. Journal of International Medical Research 2020; 48(8) doi: 10.1177/0300060520946872
|
| 12 |
Kun Guo, Yinkun Liu, Haijun Zhou, Zhi Dai, Jubo Zhang, Ruixia Sun, Jie Chen, Qianglin Sun, Wenjing Lu, Xiaonan Kang, Pei Chen. Involvement of protein kinase C β–extracellular signal‐regulating kinase1/2/p38 mitogen‐activated protein kinase–heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Science 2008; 99(3): 486 doi: 10.1111/j.1349-7006.2007.00702.x
|
| 13 |
Ch. Paganetti, A. Heigl, R. Rosenberg, M. Vetter, J. Haslbauer, M. Steuerwald. Case report: 65-year-old man with metachronous left sided adrenal metastasis of hepatocellular carcinoma. International Journal of Surgery Case Reports 2024; 119: 109683 doi: 10.1016/j.ijscr.2024.109683
|
| 14 |
D.-P. Ou, Y.-M. Tao, Z.-G. Chang, F.-Q. Tang, L.-Y. Yang. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally. Digestive and Liver Disease 2006; 38(4): 262 doi: 10.1016/j.dld.2005.10.027
|
| 15 |
Wei-Ren Liu, Meng-Xin Tian, Lei Jin, Liu-Xiao Yang, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Jia Fan, Ying-Hong Shi. High Levels of Hepatitis B Surface Antigen are Associated with Poorer Survival and Early Recurrence of Hepatocellular Carcinoma in Patients with Low Hepatitis B Viral Loads. Annals of Surgical Oncology 2015; 22(3): 843 doi: 10.1245/s10434-014-4043-5
|
| 16 |
Biyu Liu, Qi Wang, Tingting Mei, Jiasheng Zheng, Wenfeng Gao, Chunwang Yuan, Kang Li, Yonghong Zhang. Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1106333
|
| 17 |
Rong-yun Mai, Jie Zeng, Wei-da Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guo-bin Wu, Le-qun Li, Liang Ma, Jia-zhou Ye, Tao Bai. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07969-4
|
| 18 |
Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Pietro Filippini, Caterina Sagnelli, Nicola Coppola. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World Journal of Hepatology 2014; 6(6): 384-393 doi: 10.4254/wjh.v6.i6.384
|
| 19 |
Wei-Dong Pan, Rong-Qin Zheng, Lin Nan, He-Ping Fang, Bo Liu, Zhao-Feng Tang, Mei-Hai Deng, Rui-Yun Xu. Ultrasound-Guided Percutaneous Microwave Coagulation Therapy with a “Cooled-tip Needle” for the Treatment of Hepatocellular Carcinoma Adjacent to the Gallbladder. Digestive Diseases and Sciences 2010; 55(9): 2664 doi: 10.1007/s10620-009-1053-4
|
| 20 |
Kang Kook Choi, Sung Hoon Kim, Sae Byeol Choi, Jin Hong Lim, Gi Hong Choi, Jin Sub Choi, Kyung Sik Kim. Portal venous invasion: The single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(11): 1646 doi: 10.1111/j.1440-1746.2011.06780.x
|
| 21 |
Ui Jun Park, Yong Hoon Kim, Koo Jeong Kang, Tae Jin Lim. Risk factors for early recurrence after surgical resection for hepatocellular carcinoma. The Korean Journal of Hepatology 2008; 14(3): 371 doi: 10.3350/kjhep.2008.14.3.371
|
| 22 |
Hao Chen, Chun-Hui Yuan, Yi-Fei Yang, Chang-Qing Yin, Qing Guan, Fu-Bing Wang, Jian-Cheng Tu. Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5735869
|
| 23 |
A. Loglio, M. Iavarone, G. Grossi, M. Viganò, MG. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico. Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B. Alimentary Pharmacology & Therapeutics 2018; 48(4): 431 doi: 10.1111/apt.14848
|
| 24 |
Jindi Zeng, Jiancheng Wu, Shuijiao Pang, Feifei Wang, Xin Yu, Shouhua Zhang, Junquan Zeng, Jinlong Yan, Jianping Lian. Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway. Infectious Agents and Cancer 2023; 18(1) doi: 10.1186/s13027-023-00502-1
|
| 25 |
M. Dugum, I. Hanouneh, R. Lopez, F. Aucejo, B. Eghtesad, N. Zein. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation. Transplantation Proceedings 2015; 47(6): 1939 doi: 10.1016/j.transproceed.2015.02.021
|
| 26 |
Annamaria Sandomenico, Menotti Ruvo. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Current Medicinal Chemistry 2019; 26(11): 1994 doi: 10.2174/0929867325666180912104707
|
| 27 |
Ling-Ling He, Xiao-Li Liu, Shuan Zhang, Meng-Ge Li, Xian-Bo Wang, Yu-Yong Jiang, Zhi-Yun Yang. Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter. Gastroenterology Report 2019; 7(4): 250 doi: 10.1093/gastro/goz009
|
| 28 |
S. K. Basnayake, P. J. Easterbrook. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. Journal of Viral Hepatitis 2016; 23(7): 545 doi: 10.1111/jvh.12519
|
| 29 |
|
| 30 |
Bo Wei Xia, You Cheng Zhang, Jun Wang, Fang Hui Ding, Xiao Dong He. Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2015; 39(4): 458 doi: 10.1016/j.clinre.2014.12.003
|
| 31 |
Peipei Wang, Junjian Chen, Dabiao Chen, Ziying Lei, Zhishuo Mo, Ying Zhang. Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China. Liver Research 2024; doi: 10.1016/j.livres.2024.11.003
|
| 32 |
Yuehua Huang, Zhanhui Wang, Shengli An, Bin Zhou, Yuanping Zhou, Henry Lik‐Yuen Chan, Jinlin Hou. Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma. Journal of Medical Virology 2008; 80(4): 591 doi: 10.1002/jmv.21117
|
| 33 |
Lian-Yue Yang, Yi-Ming Tao, Di-Peng Ou, Wei Wang, Zhi-Gang Chang, Fan Wu. Increased Expression of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein 2 Correlated with Poor Prognosis of Hepatocellular Carcinoma. Clinical Cancer Research 2006; 12(19): 5673 doi: 10.1158/1078-0432.CCR-06-0022
|
| 34 |
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells. Nutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
|
| 35 |
Hui Liu, Cheng-Long Han, Bao-Wen Tian, Zi-Niu Ding, Ya-Fei Yang, Yun-Long Ma, Chun-Cheng Yang, Guang-Xiao Meng, Jun-Shuai Xue, Dong-Xu Wang, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 623 doi: 10.1080/17474124.2023.2212161
|
| 36 |
Teiji Kuzuya, Yoshiaki Katano, Takashi Kumada, Hidenori Toyoda, Isao Nakano, Yoshiki Hirooka, Akihiro Itoh, Masatoshi Ishigami, Kazuhiko Hayashi, Takashi Honda, Hidemi Goto. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus‐related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2007; 22(11): 1929 doi: 10.1111/j.1440-1746.2006.04707.x
|